Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Chitose Internasional Tbk. (CINT) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Chitose Internasional Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Chitose Internasional Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Chitose Internasional Tbk. trades at Rp166 (market cap 166B), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B). The key difference: Chitose Internasional Tbk. and Brigit Biofarmaka Teknologi Tbk. are close in size by market cap. Which is the better fit depends on your goals.

CINTOBAT
Market Cap
166B167.37B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CINT
View details
OBAT
View details

About Chitose Internasional Tbk.

PT Chitose Internasional Tbk (the Company) formerly PT Chitose Indonesia Manufacturing was established based on Notarial Deed No. 21 dated June 15, 1978 of Widyanto Pranamihardja, S.H., notary in Bandung. The name was changed to PT Chitose Internasional on October 4, 2013. The company with brand Chitose has a high market share in all product categories, including folding chair, hotel, restaurant, food coourt, office and working chair and chair school.

Read more on CINT

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT